A two-hour virtual session may help caregivers of children with cancer — a trial puts it to the test

NCT ID NCT05415007

Recruiting now Symptom relief Sponsor: Stanford University Source: ClinicalTrials.gov ↗

First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time

Summary

This trial tests whether a short virtual program called GOLD can reduce anxiety and boost resilience in caregivers of children recently diagnosed with cancer. About 40 caregivers will either receive the two-hour GOLD session or standard information. The study measures how many caregivers enroll and find the program acceptable.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: a brief virtual psychotherapeutic and psycho-educational program called GOLD
What this could lead to: If it works, this could offer a practical, scalable way to support caregivers of children with cancer.
What could go wrong: This is a small, early-stage trial with only 40 participants, so results may not apply broadly. The program is brief, and its long-term effects are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER

Contacts and locations

Locations

Stanford Cancer Institute
RECRUITING

San Francisco, California, 94305, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.